References
- Batchelor T, Loeffler J S. Primary CNS lymphoma. J Clin Oncol 2006; 24: 1281–1288
- Abrey L E, Yaholom J, Deangelis L M. Treatment for primary CNS lymphoma: the next step. J Clin Oncol 2000; 18: 3144–3150
- Loeffler J S, Ervin T J, Mauch P, Skarin A, Weinstein H J, Canellos G, Cassady J R. Primary lymphomas of the central nervous system: patterns of failure and factors that influence survival. J Clin Oncol 1985; 3: 490–494
- Ferreri A J, Abrey L E, Blay J, Borisch B, Hochman J, Neuwelt E A, et al. Summary statement on primary central nervous system lymphoma. the 8th International Conference on Malignant Lymphoma. June, 12 – 152002. LuganoSwitzerland, 2407–2414, J Clin Oncol 2003;21
- DeVita V T, Hellman S, Rosenberg S A. Cancer—Principles and Practice of Oncology6th edn. Lippincott Williams and Wilkins, Philadelphia 2001; 2330–2339
- Harney J, Pope A, Short S C. Primary central nervous system lymphoma with testicular relapse. Clin Oncol 2004; 16: 193–195
- Abrey L E, Batchelor T T, Ferreri A JM, Gospodarowicz M, Pulczynski E J, Zucca E. Report of an international workshop to standardize baseline evaluation and response criteria for primary central nervous system lymphoma. J Clin Oncol 2005; 23: 5034–5043
- Loeffler J S, Ervin T J, Mauch P, Skarin A, Weinstein H J, et al. Primary lymphomas of the central nervous system: patterns of failure and factors that influence survival. J Clin Oncol 1985; 3: 490–494
- O'Neill B P, Dinapoli R P, Kurtin P J, Habermann T M. Occult systemic non-Hodgkin's lymphoma in patients initially diagnosed as primary central nervous system lymphoma: how much staging is enough?. J Neuro Oncol 1995; 25: 67–71
- Shahab N, Doll D C. Testicular lymphoma. Semin Oncol 1999; 26: 259–269
- Visco C, Medeiros L J, Mesina O M, Rodriguez M A, Hagemeister F B, McLaughlin P. Non-Hodgkin's lymphoma affecting the testis: is it curable with doxorubicin based therapy?. Clin Lymphoma 2001; 2: 40–46
- Riemersma S A, Jordanova E S, Schop R F, Philipo K, Looijenga L H, Schuuring E. Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites. Blood 2000; 96: 3569–3577
- Drillenburg P, Pals S T. Cell adhesion receptors in lymphoma dissemination. Blood 2000; 95: 1900–1910
- Horstmann W G, Timens W. Lack of adhesion molecules in testicular diffuse centroblastic and immunoblastic B cell lymphomas as a contributory factor in malignant behavior. Virchows Arch 1996; 429: 83–90